Rchr
J-GLOBAL ID：202001016212001953
Update date: Oct. 21, 2024
Yae Toshifumi
ヤエ トシフミ | Yae Toshifumi
Affiliation and department：
Research theme for competitive and other funds (1)：
- 2013 - 2014 Circulating Tumor Cellの機能的解析と転移メカニズムの解明
Papers (40)：
-
Tomohito Takeshige, Ryo Koyama, Makiko Kohmaru, Takashi Akimoto, Junko Watanabe, Toshifumi Yae, Kenji Kido, Kazuhisa Takahashi. Isolated unilateral absence of the pulmonary artery (IUAPA) presenting with progressive interstitial shadows: A case report. Respirology case reports. 2024. 12. 10. e70048
-
Toshihiko Nishioki, Ryo Koyama, Hironao Okubo, Yuka Fukuo, Yusuke Takasaki, Toshifumi Yae, Takamitsu Banno, Kenji Kido, Kazuhisa Takahashi, Shuichiro Shiina, et al. Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report. Internal medicine (Tokyo, Japan). 2022. 62. 7. 999-1004
-
西沖 俊彦, 佐藤 匡, 本村 宏明, 竹重 智仁, 渡邊 純子, 八戸 敏史, 小山 良, 木戸 健治, 高橋 和久. コロナ自粛生活におけるCOPDの増悪頻度の臨床的検討. 日本呼吸器学会誌. 2022. 11. 増刊. 200-200
-
Fariz Nurwidya, Fumiyuki Takahashi, Wira Winardi, Ken Tajima, Yoichiro Mitsuishi, Akiko Murakami, Isao Kobayashi, Takeshi Nara, Muneaki Hashimoto, Motoyasu Kato, et al. Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib. Thoracic cancer. 2021. 12. 10. 1536-1548
-
Hiroaki Ihara, Yoichiro Mitsuishi, Motoyasu Kato, Fumiyuki Takahashi, Ken Tajima, Takuo Hayashi, Moulid Hidayat, Wira Winardi, Aditya Wirawan, Daisuke Hayakawa, et al. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway. Respiratory investigation. 2020. 58. 4. 275-284
ｍore...
MISC (5)：
-
Kenji Tsuchihashi, Osamu Nagano, Toshifumi Yae, Takatsugu Ishimoto, Takeshi Motohara, Momoko Yoshikawa, Go J. Yoshida, Takeyuki Wada, Takashi Masuko, Kaoru Mogushi, et al. ESRP1 regulated alternative splicing of CD44mRNA enhances lung colonization of metastatic cancer cell. CANCER RESEARCH. 2014. 74. 19
-
Katsutoshi Ando, Fumiyuki Takahashi, Motoyasu Kato, Norihiro Kaneko, Tokuhide Doi, Suzu Yae, Toshifumi Yae, Yoshito Hoshika, Kazuhisa Takahashi. POSSIBLE ROLE OF TOCILIZUMAB FOR CACHECTIC PATIENTS WITH INTERLEUKIN-6 EXPRESSING LUNG CANCER. RESPIROLOGY. 2013. 18. 55-55
-
Go J. Yoshida, Kenji Tsuchihashi, Toshifumi Yae, Osamu Nagano, Hideyuki Saya. ESRP1-CD44v-xCT axis as a potential therapeutic target for the metastasis. CANCER RESEARCH. 2013. 73
-
Takeyuki Wada, Osamu Nagano, Takatsugu Ishimoto, Toshifumi Yae, Yuko Kitagawa, Hideyuki Saya. Chronic inflammation and gastric carcinogenesis: the role of CD44 variant expression. CANCER RESEARCH. 2012. 72
-
八戸 敏史, 永野 修, 石本 崇胤, 本原 剛志, 玉田 真由美, 益子 高, 高橋 和久, 佐谷 秀行. CD44バリアントアイソフォームを用いた転移性乳癌細胞集団の同定(Identification of the metastatic subpopulation of mammary cancer cells by CD44 variant isoform expression). 日本癌学会総会記事. 2009. 68回. 248-248
Professional career (1)：
Return to Previous Page
